The article explores "tapping," a technique where you gently tap on specific acupressure points to supposedly relieve stress, anxiety, and other issues. Think of it like a DIY version of acupuncture, but without the needles—advocates swear by it, though skeptics want more scientific proof.

Editor’s Note: With mental health and wellness trends booming, tapping is getting attention as a quick, free stress-relief tool. Whether it’s legit or just placebo, people are curious—especially when traditional therapies feel out of reach. This piece gives a no-nonsense look at why some folks are hooked.

Measles outbreaks are popping up in unexpected places—from a small Texas clinic to a North Dakota school district—disrupting routines and sparking frustration. Parents and communities are grappling not just with the virus itself but with a growing distrust in public health, leaving many feeling misled or unprepared.

England is rolling out a groundbreaking initiative to sequence the DNA of every newborn baby within the next 10 years. This £650 million government-backed program aims to predict and prevent serious illnesses by analyzing each child’s genetic risk factors, paving the way for personalized healthcare from birth.

Big insurance companies are finally responding to public frustration by promising to cut the red tape around prior approvals—those annoying delays that leave patients waiting to find out if their treatments or tests will be covered. The key change? Faster decisions, so you might actually get an answer before leaving the doctor’s office instead of weeks later.

In a promising small trial, a new stem cell-based drug called zimislecel appears to have cured severe type 1 diabetes in 10 out of 12 participants, eliminating their need for insulin. However, the treatment might not be as effective for those with milder forms of the disease.